Bearish flow noted in Bristol Myers (BMY) Squibb with 13,714 puts trading, or 3x expected. Most active are 11/14 weekly 45.5 puts and Nov-25 49 puts, with total volume in those strikes near 5,500 contracts. The Put/Call Ratio is 1.62, while ATM IV is up over 3 points on the day. Earnings are expected on February 5th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers falls 4% to $46.41 after stopping Phase 3 Librexia ACS trial
- Bristol Myers to stop Phase 3 Librexia ACS trial of milvexian
- Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
- Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
- Bristol Myers initiated with a Sector Perform at Scotiabank